Tetra Bio-Pharma Inc.

Tetra Bio-Pharma Inc.verified

TBPMF

Price:

$0.0009

Market Cap:

$10.58M

Tetra Bio-Pharma Inc., a biopharmaceutical company, engages in the discovery and development of cannabinoid-derived drugs for inflammation, pain, ophthalmology, and oncology. The company develops PLENITUDE to treat cancer-related pain in advanced cancer patients; REBORN for the treatment of breakthrough cancer pain; Reduvo for chemotherapy-induced nausea and vomiting; ARDS-003 for the treatment of sepsis and prevention of acute respiratory distress syndrome; and SERENITY to treat cancer cachexia. It also develops PPP003 for painful dry eye and uveitis pain; and HCC011 for hepatocellular carcinoma. Tetra Bio-Pharma Inc. has an agreement with Cellvera Global Holdings LLC for the co-development...[Read more]

Industry

Biotechnology

IPO Date

2012-09-25

Stock Exchange

OTC

Ticker

TBPMF

The ROE as of July 2025 (TTM) for Tetra Bio-Pharma Inc. (TBPMF) is -467.81%

According to Tetra Bio-Pharma Inc.’s latest financial reports and current stock price. The company's current ROE is -467.81%. This represents a change of -84.70% compared to the average of -3058.24% of the last 4 quarters.

Tetra Bio-Pharma Inc. (TBPMF) Historical ROE (quarterly & annually)

How has TBPMF ROE performed in the past?

The mean historical ROE of Tetra Bio-Pharma Inc. over the last ten years is -2304.81%. The current -467.81% ROE has changed -79.70% with respect to the historical average. Over the past ten years (40 quarters), TBPMF's ROE was at its highest in in the August 2015 quarter at 324.52%. The ROE was at its lowest in in the November 2021 quarter at -12106.70%.

Quarterly (TTM)
Annual

Average

-2304.81%

Median

-64.36%

Minimum

-21424.84%

Maximum

258.35%

Tetra Bio-Pharma Inc. (TBPMF) ROE by Quarter and Year

Discovering the peaks and valleys of Tetra Bio-Pharma Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 17.89%

Maximum Annual ROE = 258.35%

Minimum Annual Increase = -238.83%

Minimum Annual ROE = -21424.84%

Quarterly (TTM)
Annual
YearROEChange
2021-21424.84%17.89%
2020-119.08%87.36%
2019-63.56%75.31%
2018-36.25%-34.99%
2017-55.77%-14.40%
2016-65.15%-125.22%
2015258.35%-238.83%
2014-186.09%-86.02%
2013-1331.04%5.29%
2012-24.68%-78.51%

Tetra Bio-Pharma Inc. (TBPMF) Average ROE

How has TBPMF ROE performed in the past?

The current ROE of Tetra Bio-Pharma Inc. (TBPMF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-7202.49%

5-year avg

-4339.90%

10-year avg

-2304.81%

Tetra Bio-Pharma Inc. (TBPMF) ROE vs. Peers

How is TBPMF’s ROE compared to its peers?

Tetra Bio-Pharma Inc.’s ROE is less than Intellipharmaceutics International Inc. (27.35%), less than Antibe Therapeutics Inc. (0%), greater than Satellos Bioscience Inc. (-40.16%), greater than Sio Gene Therapies Inc. (-51.42%), less than Magenta Therapeutics, Inc. (0%), greater than TRACON Pharmaceuticals, Inc. (-78.26%), greater than ARCA biopharma, Inc. (-32.82%), less than Ceapro Inc. (0%), less than Oncotelic Therapeutics, Inc. (295.12%), greater than PhaseBio Pharmaceuticals, Inc. (-13.26%), greater than Processa Pharmaceuticals, Inc. (-14.93%), greater than Kaleido Biosciences, Inc. (-44.15%), less than null (0.22%), greater than null (-319.58%), less than null (0%),

Build a custom stock screener for Tetra Bio-Pharma Inc. (TBPMF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tetra Bio-Pharma Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tetra Bio-Pharma Inc. (TBPMF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tetra Bio-Pharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Tetra Bio-Pharma Inc.'s ROE?

How is the ROE calculated for Tetra Bio-Pharma Inc. (TBPMF)?

What is the highest ROE for Tetra Bio-Pharma Inc. (TBPMF)?

What is the 3-year average ROE for Tetra Bio-Pharma Inc. (TBPMF)?

What is the 5-year average ROE for Tetra Bio-Pharma Inc. (TBPMF)?

How does the current ROE for Tetra Bio-Pharma Inc. (TBPMF) compare to its historical average?